3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 4
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Vomiting
2
Carcinoma, Non-Small-Cell Lung
2
Somatoform Disorders
1
Neoplasms
1
Nausea
1
Multiple Myeloma
1
Lymphoma
1
Hematologic Neoplasms
1
Delirium
1
Breast Neoplasms
1
Interventions
Dexamethasone
5
Aprepitant
5
Palonosetron
3
Ondansetron
3
Granisetron
3
Calcium Dobesilate
3
Metoclopramide
2
naldemedine
1
dolasetron
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
alizapride
1
Tropisetron
1
Tablets
1
Duration of Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Nausea
×
dexamethasone 21-phosphate
×
Clear all
NCT01636947
2018-09-25
KMEC
Merck Sharp & Dohme LLC
Phase 4
Completed
494 enrolled
14 charts